Opens in a new tab

Technical & Safety - Paxman Scalp Cooling System

Offer scalp cooling 
with confidence

Scalp cooling efficacy for reducing chemotherapy-induced alopecia has been proven in many clinical trials and within numerous centres for all solid tumour cancers.

Efficacy varies based on a series of factors, with the chemotherapy drug regimens being the primary influence.

Taxane-based regimens see the highest rates of hair retention, and although anthracycline regimens see a lower level of efficacy, scalp cooling with anthracyclines is still beneficial. As a safe and tolerable treatment, it is also proven to support regrowth, help with the prevention of persistent chemotherapy-induced alopecia (PCIA), and improve quality of life.

Request technical information

For IFUs and further technical information, please complete the form below.

Implementation & support

Learn more

The Paxman Scalp Cooling System Clinical Evidence Brochure

Download

The science behind 
scalp cooling

Learn more
Get the Paxman System

Wherever you are in the world, it’s easy to give patients access to our chemotherapy side effect management solutions and a degree of control. Fill out the form to get started.

Get Paxman in your country with our global locator